Skip to Content

Fabrazyme Prices, Coupons and Patient Assistance Programs

Fabrazyme (agalsidase beta) is a member of the lysosomal enzymes drug class and is commonly used for Fabry Disease.

Fabrazyme Prices

The cost for Fabrazyme intravenous powder for injection 5 mg is around $942 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Fabrazyme price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Powder For Injection

5 mg Fabrazyme intravenous powder for injection
from $941.80 for 1 powder for injection
Quantity Per unit Price
1 $941.80 $941.80

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

35 mg Fabrazyme intravenous powder for injection
from $6,536.69 for 1 powder for injection
Quantity Per unit Price
1 $6,536.69 $6,536.69

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Fabrazyme Coupons and Rebates

Fabrazyme offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Fabrazyme Charitable Access Program (CAP): Program provides medication to patients who medically need it and are uninsured or underinsured; for additional information contact the program at 800-745-4447, option 3.

Applies to:Fabrazyme
Number of uses:Per prescription until program expires

Fabrazyme CareConnectPSS Copay Assistance Program: Eligible patients may receive assistance paying for co-pays, deductibles and co-insurance as well as eligible out-of-pocket drug and infusion-related expenses; for additional information contact the program at 800-745-4447, option 3.

Applies to:Fabrazyme
Number of uses:Per prescription until program expires

Patient Assistance Programs for Fabrazyme

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Fabrazyme (agalsidase beta) IV; Infusion

Provider: Sanofi Genzyme Charitable Access Program

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. Qualified individuals with Lysosomal Storage Disorders (Gaucher Disease, Fabry Disease, MPS1 and Pompe Disease) whose physicians have recommended treatment may be eligible for this program. This is considered a temporary funding program. Patients and their families are expected to continue exploring alternative resources with the assistance of a Sanofi Genzyme case manager.

Applicable drugs:

  • Fabrazyme (agalsidase beta) IV; Infusion